HeartFlow Wants To Accelerate Adoption Of AI-Powered Heart Disease Test With $2.4Bn SPAC Deal
Executive Summary
SPAC Longview Acquisition Corp. said it will take Heartflow public in a transaction that will provide the combined company with $400m in cash.
You may also be interested in...
Minute Insight: HeartFlow Drops SPAC Plan; Names New Leadership
John Farquhar, who served as HeartFlow’s COO since August 2021, will now lead the cardiac imaging company as CEO. The move comes just weeks after HeartFlow terminated plans to go public through a merger with a special purpose acquisition company.
Cardiovascular Catch-Up: TAVR Withstands Delta Virus So Far; Stereotaxis Robot Succeeds In Trial
The impact of the Delta variant of COVID-19 on procedure volumes remains a major concern for transcatheter valve makers, Abbott launches a new PFO closure device, and more highlights from the cardiovascular technology market in early October.
LumiraDX Goes Public In SPAC Merger
Investors have been wary of LuminaraDX since its placement on NASDAQ, driving the share price down.